Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hovione Technology is a specialist drug delivery device company that designs, develops, and licenses innovative inhalation devices. Spun out from the global CDMO Hovione, the company focuses on providing cost-effective and high-performance dry powder inhalers (DPIs) for respiratory and systemic applications. Their portfolio includes the TwinCaps, a widely used disposable DPI, and other advanced platforms like the Papillon and 88-8. The company operates by partnering with pharmaceutical firms to integrate their device technology with specific drug formulations. Their technology is particularly noted for its ability to deliver high doses of powder, making it suitable for antibiotics and antivirals. Headquartered in Hong Kong with R&D in Portugal, they provide a full suite of services from device design to clinical supply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hovione Technology.